Keywords: AML; acute myeloid leukemia; DFS; disease-free survival; DLBCL; diffuse large B-cell lymphoma; DSPC; 1,2-distearoyl-sn-glycero-3-phosphocholine; DSPE; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine; EPR; enhanced permeation and retention; MB; molecular b
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: BMB; bone marrow biopsy; CNS; central nervous system; CT; contrast enhanced computed tomography; DLBCL; diffuse large B-cell lymphoma; EBV; epstein Barr virus; FDG; 18F-flurodeoxyglucose; MRI; magnetic resonance imaging; MTV; metabolic tumor volume; NPV;
Keywords: DLBCL; diffuse large B-cell lymphoma; R-CHOP; rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone; NHL; non-Hodgkin lymphoma; GEP; gene expression profiling; COO; cell-of-origin; GCB; germinal center B-cell; ABC; activated B-cell; PMBL;
Keywords: Teratoma; ovarian neoplasm; lymphoma; CT; Computed tomography; DLBCL; diffuse large B-cell lymphoma; DLBCL-CI; diffuse large B-cell lymphoma associated with chronic inflammation; PET; positron emission tomography; R-CHOP; rituximab, cyclophosphamide, hydr
Keywords: CHOP; cyclophosphamide, hydroxydaunorubicin, Oncovin (vincristine), prednisone; FLIPI; Follicular Lymphoma International Prognostic Index; GCB; germinal center B cell; IPI; International Prognostic Index; MALT; mucosa-associated lymphoid tissue; NK; natur
Keywords: CD; Castleman disease; CRP; C-reactive protein; CT; Computed tomography; DOI; Day of illness; ESR; Erythrocyte sedimentation rate; HHV; Human herpesvirus; IL; Interleukin; MCD; Multicentric Castleman disease; R-CHOP; Rituximab plus cyclophosphamide, doxor
Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type with significant T-cell immune response
Keywords: B cell; lymphoma; primary cutaneous diffuse large B-cell lymphoma; leg type; regression; PCFCL; primary cutaneous follicle center lymphoma; PCMZL; primary cutaneous marginal zone lymphoma; PCDLBCL-LT; primary cutaneous diffuse large B-cell lymphoma, leg t
Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: A Danish population-based cohort study
Keywords: DLBCL; Elderly; Comorbidity and treatment; Chemotherapy; R-CHOP;
GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus
Keywords: ABC; abacavir; ABVD; adriamycin, bleomycin, vinblastine and dacarbazine; Ara-C; cytosine arabinoside; AZT; zidovudine; BCNU; carmustine; BEACOPP; bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone; CDC; Centers fo
Recomendaciones de GESIDA/PETHEMA sobre el diagnóstico y tratamiento de los linfomas en pacientes infectados por el virus de la inmunodeficiencia humana
Keywords: Linfoma no hodgkiniano; Linfoma de Hodgkin; VIH; Sida; Tratamiento antirretroviral; Non-Hodgkin's lymphoma; Hodgkin's lymphoma; HIV; AIDS; Antiretroviral therapy; ABC; abacavir; ABVD; adriamicina, bleomicina, vinblastina y dacarbazina; Ara-C; arabinósido
Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOP
Keywords: FLG3; Prognosis; R-CHOP; Survival; Treatment;
What is the optimal initial management of the older MCL patient?
Keywords: Mantle cell lymphoma; Elderly patients; Induction therapy; Maintenance therapy; R-CHOP; Bendamustine; Cytarabine; Lenalidomide; Bortezomib; Toxicity;
Optimizing initial therapy in DLBCL
Keywords: Diffuse large B-cell lymphoma; R-CHOP; Prognostic factors; TMTV; CNS prophylaxis;
Transient congenital dilated cardiomyopathy after maternal R-CHOP chemotherapy during pregnancy
Keywords: CHOP; cyclophosphamide doxorubicin vincristine, prednisolone chemotherapy-regimen; DLBCL; diffuse large B-cell lymphoma; GA; gestational age; NHL; non-Hodgkin lymphoma; NTP; National Toxicology Program; pBNP; pro-brain natriuretic peptide; R-CHOP; Rituxim
HIP1 expression predicts outcome in breast cancer patients treated with neoadjuvant chemotherapy
Keywords: HIP1; huntingtin-interacting protein 1; p; patients; IHC; immunohistochemistry (IHC); TTP; time to progression; OS; overall survival; TNBC; triple negative breast cancer; DLBCL; diffuse large B-cell lymphoma; R-CHOP; rituximab, cyclophosphamide, doxorubic
Primary cardiac diffuse large B-cell lymphoma with concurrent high MYC and BCL2 expression in an immunocompetent Chinese elderly woman
Keywords: DLBCL; Diffuse large B-cell lymphoma; PCL; Primary cardiac lymphoma; MRI; Magnetic resonance imaging; HBsAg; Hepatitis B virus surface antigen; HIV; Human immunodeficiency virus; NHL; Non-Hodgkin lymphoma; GCB; Germinal center B-cell-like; ABC; Activated
Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: An overview about well-established and recently emerging clinical data
Keywords: ABCC1/MRP; ATP binding cassette subfamily C member 1/ multidrug resistance protein; ABVD; doxorubicine-bleomycin-vinblastine-dacarbazine; AC; doxorubicin-cyclophosphamide; ANC; absolute neutrophil count; ASCO; American Society of Clinical Oncology; AUC; a
Tumor necrosis at FDG-PET is an independent predictor of outcome in diffuse large B-cell lymphoma
Keywords: Diffuse large B-cell lymphoma; FDG-PET; Necrosis; Prognosis; R-CHOP;
CD56â extranodal natural killer (NK)/T-cell lymphoma, nasal type presenting as skin ulcers in a white man
Keywords: CD56; natural killer/T cell; rituximab; TÂ cell lymphoma; EBER; Epstein-Barr virus-encoded small RNAs; EBV; Epstein-Barr virus; ENKTL; extranodal natural killer/T-cell lymphoma; NK; natural killer; PET/CT; positron emission tomography/computed tomograph
Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma
Keywords: Anti-CD20 monoclonal antibody; Chemoimmunotherapy; DLBCL; Non-Hodgkin lymphoma; R-CHOP;
Effect of R-CHOP chemotherapy on liver and mediastinal blood pool 18F-FDG standardized uptake values in patients with non-Hodgkin's lymphoma
Keywords: PET; Non-Hodgkin's lymphoma; Chemotherapy; R-CHOP; Standardized uptake value;
R-CHOP therapy alone for limited-stage follicular lymphoma
Keywords: Follicular lymphoma; Immunochemotherapy; Limited-stage; Rituximab; R-CHOP;
Progressive multifocal leukoencephalopathy (PML) in a patient with lymphoma treated with rituximab: A case report and literature review
Keywords: PML; R-CHOP; Rituximab; Lymphoma
Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy
Keywords: Diffuse large B-cell lymphoma; Non-hodgkin lymphoma; Beta 2-microglobulin; R-CHOP; Progression-free survival;
Prognostic Value of Anemia and C-Reactive Protein Levels in Diffuse Large B-Cell Lymphoma
Keywords: Anemia; C-reactive protein; Diffuse large B-cell lymphoma; Hemoglobin; Prognosis; R-CHOP
American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
Keywords: ALT; alanine aminotransferase; anti-HBc; antibody to hepatitis B core antigen; anti-HBs; antibody to hepatitis B surface antigen; AST; aspartate aminotransferase; CHOP; cyclophosphamide, doxorubicin, vincristine, and prednisone; CI; confidence interval; F
R-CHOP versus R-COMP: Are They Really Equally Effective?
Keywords: Diffuse large B-cell lymphoma; outcome; R-CHOP; R-COMP;
Diffuse large B-cell lymphoma in elderly patients: A retrospective analysis
Keywords: DLBCL; Elderly; R-CHOP
What Determines Therapeutic Choices for Elderly Patients With DLBCL? Clinical Findings of a Multicenter Study in Portugal
Keywords: DLBCL; Elderly; R-CHOP; Treatment;
Similar outcomes in Asian and Western patients with diffuse large B-cell lymphoma treated with R-CHOP
Keywords: DLBCL; Race; Rituximab; Chemoimmunotherapy; R-CHOP
Pulmonary Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Associated with Granulomatous Inflammation in a Child with Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome)
Keywords: CT; Computed tomography; EBV; Epstein-Barr virus; LPD; Lymphoproliferative disorder; MALT; Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue; PET; Positron emission tomography; R-CHOP; Rituximab, cyclophosphamide, hydroxydaunorubicin,
18F-FDG-PET/CT in lymphoma: Two decades of experience
Keywords: ABVD; adriamycin, bleomycin, vinblastine, dacarbazine; BEACOPP; bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone; NK cells; natural killer cells; REAL classification; Real European-American Classification of Ly
Positron Emission Tomographic Scans in Lymphoma: Convention and Controversy
Keywords: ABVD; doxorubicin, bleomycin, vinblastine, dacarbazine; BEACOPP; bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone; CT; computed tomography; DLBCL; diffuse large B-cell lymphoma; FDG; fluorine 18 fluorodeoxyglucose
Case series of duodenal follicular lymphoma, observed by magnified endoscopy with narrow-band imaging
Keywords: MALT; mucosa-associated lymphoid tissue; NBI; narrow-band imaging; R-CHOP; rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy;
Bortezomib-Induced Tumor Lysis Syndrome in a Patient With HIV-Negative Plasmablastic Lymphoma
Keywords: Diffuse large B-cell lymphoma; Non-Hodgkin lymphoma; R-CHOP
Involved Field Radiation After Autologous Stem Cell Transplant for Diffuse Large B-Cell Lymphoma in the Rituximab Era
Keywords: Diffuse large B-cell lymphoma; ASCT; Rituximab; R-CHOP; IFRT;
The Sarcoid-Lymphoma Syndrome
Keywords: Brincker; FDG uptake; Immune dysregulation; PET imaging; R-CHOP; Sarcoidosis
Management of Mantle Cell Lymphoma: Key Challenges and Next Steps
Keywords: Bendamustine; HyperCVAD; Lenalidomide; MIPI; R-CHOP; Rituxumab; Temsirolimus; Transplantation
Mutation or polymorphism of the CD20 gene is not associated with the response to R-CHOP in diffuse large B cell lymphoma patients
Keywords: CD20; R-CHOP; DLBCL; Rituximab; Mutation; Polymorphism
Monoclonal antibody as therapy for malignant lymphomas
Keywords: Rituximab; R-CHOP; Follicular lymphoma; Diffuse large B-cell lymphoma; Radio-labelled antibodies; Monoclonal antibodiesRituximab; R-CHOP; Lymphome folliculaire; Lymphome à grandes cellules B; Anticorps marqués radioactivement; Anticorps monoclonaux
Non-Hodgkin Lymphoma: Diagnosis and Treatment
Keywords: ACVBP; doxorubicin (Adriamycin), cyclophosphamide, vindesine, bleomycin, and prednisone; CHOP; cyclophosphamide, hydroxydaunomycin (doxorubicin), vincristine (Oncovin), and prednisone; CNS; central nervous system; CVP; cyclophosphamide, vincristine, and p